✦ LIBER ✦

A multifaceted intervention to narrow the evidence-based gap in the treatment of acute coronary syndromes: Rationale and design of the Brazilian Intervention to Increase Evidence Usage in Acute Coronary Syndromes (BRIDGE-ACS) cluster-randomized trial

✍ Scribed by Otávio Berwanger; Hélio P. Guimarães; Ligia N. Laranjeira; Alexandre B. Cavalcanti; Alessandra Kodama; Ana Denise Zazula; Eliana Santucci; Elivane Victor; Uri A. Flato; Marcos Tenuta; Vitor Carvalho; Vera Lucia Mira; Karen S. Pieper; Luiz Henrique Mota; Eric D. Peterson; Renato D. Lopes

Book ID: 116192733
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 731 KB
Volume: 163
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2012.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and rationale of the RadIal Vs. f

Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes

✍ Sanjit S. Jolly; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Vicen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Design and rationale of the Treatment of

Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy

✍ Philippe Gabriel Steg; Shamir R. Mehta; Charles V. Pollack Jr.; Christoph Bode; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Design and rationale of the AngioSeal ve

Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segment elevation acute coronary syndrome patients

✍ de Andrade, Pedro; e Mattos, Luiz Alberto; Tebet, Marden; Rinaldi, Fábio; Esteve 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 404 KB

The Early Glycoprotein IIb/IIIa Inhibiti

The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale

✍ Robert P. Giugliano; L. Kristin Newby; Robert A. Harrington; C. Michael Gibson; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

The effect of a short one-on-one nursing

The effect of a short one-on-one nursing intervention on knowledge, attitudes and beliefs related to response to acute coronary syndrome in people with coronary heart disease: A randomized controlled trial

✍ Sharon McKinley; Kathleen Dracup; Debra K. Moser; Barbara Riegel; Lynn V. Doerin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 488 KB

Rationale and design of the Anti-Xa Ther

Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome

✍ C. Michael Gibson; Jessica L. Mega; Paul Burton; Shinya Goto; Freek Verheugt; Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 428 KB